- Home
- RXRX vs FBK Comparison
RXRX vs FBK Comparison
Compare RXRX & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- FBK
- Stock Information
- Founded
- RXRX 2013
- FBK 1906
- Country
- RXRX United States
- FBK United States
- Employees
- RXRX N/A
- FBK N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- FBK Major Banks
- Sector
- RXRX Health Care
- FBK Finance
- Exchange
- RXRX Nasdaq
- FBK Nasdaq
- Market Cap
- RXRX 2.4B
- FBK 2.1B
- IPO Year
- RXRX 2021
- FBK 2016
- Fundamental
- Price
- RXRX $4.71
- FBK $52.90
- Analyst Decision
- RXRX Buy
- FBK Buy
- Analyst Count
- RXRX 4
- FBK 5
- Target Price
- RXRX $7.25
- FBK $59.00
- AVG Volume (30 Days)
- RXRX 17.0M
- FBK 286.4K
- Earning Date
- RXRX 11-05-2025
- FBK 10-14-2025
- Dividend Yield
- RXRX N/A
- FBK 1.43%
- EPS Growth
- RXRX N/A
- FBK N/A
- EPS
- RXRX N/A
- FBK 1.94
- Revenue
- RXRX $64,596,000.00
- FBK $410,807,000.00
- Revenue This Year
- RXRX $24.09
- FBK $35.00
- Revenue Next Year
- RXRX $20.99
- FBK $21.58
- P/E Ratio
- RXRX N/A
- FBK $27.36
- Revenue Growth
- RXRX 30.14
- FBK N/A
- 52 Week Low
- RXRX $3.79
- FBK $38.83
- 52 Week High
- RXRX $12.36
- FBK $58.88
- Technical
- Relative Strength Index (RSI)
- RXRX 42.97
- FBK 56.74
- Support Level
- RXRX $4.51
- FBK $51.62
- Resistance Level
- RXRX $5.09
- FBK $53.50
- Average True Range (ATR)
- RXRX 0.26
- FBK 1.06
- MACD
- RXRX 0.04
- FBK -0.28
- Stochastic Oscillator
- RXRX 40.63
- FBK 39.60
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.